Mai Iwasa

High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer

Satoru Takahashi, T. Toyama, H. Yamashita, 2011, International Journal of Clinical Oncology.

Management of Recurrent Breast Cancer without Systemic Therapy but with Natural Menopause as Endocrine Therapy: A Report of Two Cases

T. Toyama, H. Yamashita, Y. Fujii, 2011 .

Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy

Satoru Takahashi, T. Toyama, H. Yamashita, 2013, Case reports in oncological medicine.

High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients.

N. Kondo, Satoru Takahashi, T. Toyama, 2012, Japanese journal of clinical oncology.

miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.

Satoru Takahashi, T. Toyama, H. Yamashita, 2013, Endocrine-related cancer.

The Role of MicroRNAs in Estrogen Receptor α-Positive Human Breast Cancer

T. Toyama, H. Yamashita, Y. Fujii, 2011 .

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer

Satoru Takahashi, T. Toyama, H. Yamashita, 2011, Breast Cancer Research and Treatment.

Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor‐positive breast cancer in Japanese women

Satoru Takahashi, T. Toyama, H. Yamashita, 2011, Cancer science.